Drug Enforcement Administration (DEA)
Executive Profile (BLUF)
The Drug Enforcement Administration is the United States federal law enforcement agency responsible for combating drug trafficking and distribution within the US and internationally. Operating under the Department of Justice, the DEA’s mandate covers investigation and prosecution of major drug trafficking organizations (DTOs), enforcement of the Controlled Substances Act, and international coordination on narcotics interdiction. The DEA maintains the largest US law enforcement foreign presence — 93 offices in 69 countries — making it effectively an intelligence-law enforcement hybrid with broad HUMINT networks inside transnational criminal organizations. In the strategic context, the DEA’s most significant operations target: Sinaloa Cartel and Cartel Jalisco Nueva Generación (CJNG) fentanyl supply chains; Primeiro Comando da Capital (PCC) and Comando Vermelho Brazilian networks; and the Hezbollah-TCO financial nexus (particularly in the Triple Frontier, West Africa, and Lebanon). The DEA’s intelligence collection on cartel leadership and TCO financing is a primary source for US Treasury OFAC sanctions designations.
Key Relationships
- Department of Justice — parent agency; AG authority
- Sinaloa Cartel — primary adversary; El Chapo prosecution; El Mayo surrender facilitation
- Cartel Jalisco Nueva Generación (CJNG) — primary adversary; $10M bounty on El Mencho
- Mexico — primary bilateral law enforcement partner/counterpart; sovereignty tension over DEA operations
- Colombia — second bilateral priority; FARC dissidents + Gulf Clan cocaine operations
- Brazil — partnership on PCC/Comando Vermelho transnational operations
- Department of Homeland Security (DHS) — interagency coordination on border narcotics interdiction
- FBI — overlapping jurisdiction on TCO financial investigations; formal deconfliction protocols
- Europol — primary European counterpart for transatlantic trafficking coordination